23andMe Looking at Hereditary Colorectal Cancer Syndrome

Personal genetics specialist, 23andMe received a nod from FDA for a genetic health risk report on a hereditary colorectal cancer syndrome. FDA's nod for the Mountain View, CA-based company's MUTYH-Associated Polyposis Genetic Health Risk report follows a previous authorization for the BRCA1/BRCA2 (Selected Variants) Genetic Health Risk report in March 2018. The MUTYH-Associated Polyposis report was submitted to the FDA using the 510(k) submission pathway, enabled by the BRCA decision in...

from A via a.sfakia on Inoreader http://bit.ly/2Ujh04I